SlideShare a Scribd company logo
Signal Detection of
Adverse Medical Device
Events in the
FDA MAUDE Database
Eric Brinsfield, MS
Presenter & Research Collaborator

David Olaleye, MSCE, PhD
Author & Primary Research Statistician

SAS Institute Inc.
Cary, NC
                         Company Confidential - For Internal Use Only
                     Copyright © 2010, SAS Institute Inc. All rights reserved.
Disclosure Statement

 Both presenters are employees of SAS Institute
 We have no conflicts of interest



 Disclaimer

The views and opinions expressed in the following
PowerPoint slides are those of the individual presenters
and should not be attributed to ISPE or to SAS Institute.



                                                                                 2


                         Company Confidential - For Internal Use Only
                     Copyright © 2010, SAS Institute Inc. All rights reserved.
Study Objectives
Determine if text mining can be used to:
   Detect signals of adverse events in
    spontaneous reporting data
   Better understand or triage signals
    generated by traditional disproportionality
    methods

            Phase 1:
                Evaluate unsupervised text mining
                Using FDA MAUDE database
                Focused on stents
                                                                                     3


                         Company Confidential - For Internal Use Only
                                                                                 3
                     Copyright © 2010, SAS Institute Inc. All rights reserved.
Definitions
 Safety Signal
   “A report or reports of an event with an unknown
    causal relationship to treatment that is recognized as
    worthy of further exploration and continued surveillance.”
     » Council for International Organizations of Medical
       Sciences (CIOMS)
 “Recognition” is often the results of
   Analytical or automatic signal detection methods that look
    for unexpected patterns in data sources such as:
     » Spontaneously reported data
     » Observational healthcare data
     » Insurance claims data


                                                                                    4


                            Company Confidential - For Internal Use Only
                        Copyright © 2010, SAS Institute Inc. All rights reserved.
Methods

 Data Source = MAUDE
     FDA Spontaneous Reporting System Database for Med. Devices
      MAUDE - Manufacturer and User Facility Device Experience
     Contains the narrative entered by the reporter

 Target Devices
     endovascular graft system and coronary stent devices
     devices classified as a stent in the “product_category_code”:
      » MAF, MIH, NIN, NIO, NIP, NIM, and NIQ
      » http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPCD/classif
        ication.cfm?ID=896


                                                                                           5


                               Company Confidential - For Internal Use Only
                                                                                       5
                           Copyright © 2010, SAS Institute Inc. All rights reserved.
MAUDE (2001-2008)
Spontaneous “safety” reports on medical devices
Strengths:
   Only surveillance system which covers devices
    marketed in the entire US
   Largest number of case reports on adverse outcomes
    and malfunctions for medical devices
   Provides opportunity to detect signals of new, rare
    and unusual adverse clinical outcomes
    » Usually warrants further investigation
   Includes narrative description of events
    » Better than AERS which does not include narrative

                                                                                    6


                            Company Confidential - For Internal Use Only
                        Copyright © 2010, SAS Institute Inc. All rights reserved.
Characteristics of Spontaneous Report
 Suitable for hypotheses generation; not for confirmation or
  rates computation
 Exhibit under-reporting and other reporting biases; lack of
  control group, etc.
 Data quality, ascertainment, accuracy and completeness of
  information are usually poor
 Includes events and incidents not causally related to
  medical device exposure
 Does not distinguish between label versus off-label uses of
  approved products
 Contains minimal or no patient history and other potential
  causal factors
 Do not provide estimates of exposure (worse in drugs)                              7


                             Company Confidential - For Internal Use Only
                         Copyright © 2010, SAS Institute Inc. All rights reserved.
Study Design: Case-Series
                  Source Population
     All MAUDE reports received between 2006 – 2010
                      (N=35954)


Study Device Cohort                                           Study Events
MAUDE reports for stents                                      •       Death (D)
with product codes:                                           •       Injury (I)
   MAF, MIH, NIN, NIO,                                        •       Malfunctions (M)
   NIP, NIM, and NIQ                                          •       Other (O)


           Device-Adverse Outcomes Pairs
                       (N=28)
                                                                                         8


                          Company Confidential - For Internal Use Only
                      Copyright © 2010, SAS Institute Inc. All rights reserved.
Analysis Steps

1. Attempt analysis using text mining alone
     Ignore device
     Evaluate if general text mining provides any insights
2. Perform standard disproportionality analysis on
   structured data
     PRR, EBGM, Adj. Residual
3. Identify device-AE pairs that have:
     High scores
     Especially in the “Other” classification
4. Investigate the device with text mining
     Include all outcome classifications

                                                                                     9


                             Company Confidential - For Internal Use Only
                         Copyright © 2010, SAS Institute Inc. All rights reserved.
Text Mining Process

 Parse terms to create documents-terms frequency matrix
 Use singular value decomposition (SVD) to measure
  association and perform hierarchical clustering
 Use entropy method to cluster SVDs for documents
  classification




                                                                                 10


                         Company Confidential - For Internal Use Only
                     Copyright © 2010, SAS Institute Inc. All rights reserved.
Sample Narrative - Injury
Example of Manufacturer Report - Injury
 the product labeling for a p154 states that this product is indicated for
  use in pts with obstruction of major biliary ducts. the product labeling
  also states that the stent may be increased post-placement by
  expanding with a larger diameter balloon. the following was obtained
  through conversation with the user facility on 1/15/98. after deciding that
  a ptca procedure in a renal artery did not yield adequate results, the md
  attempted to place a medium biliary stent in the artery. the physician
  reported to co. that he had difficulty visualizing the stent and that it was
  difficult to place. he deployed the stent, but was not satisfied with the
  outcome. in response, he decided to place a second stent inside of the
  first. however, the stents interlocked and the physician decided to
  remove both stents, he was able to withdraw the stent up to sheath tip in
  the femoral artery, but needed a vascular surgeon to completely remove
  them. info regarding the type of removal procedure has not been
  provided to co. the physician further stated that he believes that the first
  stent had not fully opened. it was mounted on a meditech glidex balloon.


                                                                                             11


                                     Company Confidential - For Internal Use Only
                                 Copyright © 2010, SAS Institute Inc. All rights reserved.
Concept Linking and Exploration




                                                                           12


                   Company Confidential - For Internal Use Only
               Copyright © 2010, SAS Institute Inc. All rights reserved.
Text mining clusters over all reports




                                                                            13


                    Company Confidential - For Internal Use Only
                Copyright © 2010, SAS Institute Inc. All rights reserved.
Text Mining Over All Reports

 Results are interesting
 But inconclusive
 Lose track of the device
 But may detect new trends for all stent devices in study


Cannot really do comparisons due to lack of denominator.
(Same problems as always with spontaneous reports.)


Next, run disproportionality to narrow the focus…

                                                                                   14


                           Company Confidential - For Internal Use Only
                       Copyright © 2010, SAS Institute Inc. All rights reserved.
Disproportionality Results for
   Carotid Stent (NIM)

                                                                                          Adjusted        MGPS
Adverse Event                                        Freq                                 Residual      (EBGM)
Death                                                       276                                   0.8    0.86728

Injury                                                  2043                                      1.1   1.130264

Malfuntion                                                  271                                   0.4   0.424803

Other                                                           24                                1.6   3.648191

 * Adjusted Residual:   Flagged at values over 1.5
   EBGM:                Flagged at values over 2.0


                                                                                                                   15


                                          Company Confidential - For Internal Use Only
                                      Copyright © 2010, SAS Institute Inc. All rights reserved.
Target for Text Mining Evaluation

 NIM showed high proportion of “Other”
    Based on relative percentage of reports
    Based on signal scoring algorithms
    All methods suggested a flag
    Although only 24 cases, the method could show promise
 Run text mining against all NIM reports
    Include all outcomes to fully understand reports
    Look for possible explanations or hypotheses




                                                                                    16


                            Company Confidential - For Internal Use Only
                        Copyright © 2010, SAS Institute Inc. All rights reserved.
N
Text Mining Clusters for NIM
+percutaneous +unk dissection performance +unstable repaired                                376
+malfunction 'device remains implanted'
reactions collapsing +'premature deployment' cracks +'product quality                           41
issue' replaced performance collapsed
malfunction fractures +fracture +'inaccurate delivery' fractured                            846
malfunctions drift +'premature deployment'
+normal dissection +unk 'no information' +na collapsing unk fractured                           69
'device issue' broke 'no known device problem' +break broken +'shaft                        227
break' reaction reactions
abnormal +fracture +continuous +bent cracks unk +break fractured                                65
filter +na 'difficult to advance' breaks reaction +bent +malfunction                        150
replaced
'device remains implanted' collapsed 'no flow' performance +crack                               44
+break +collapse filter
fractured repair +crack breaks +collapse +'product quality issue' 'no                           31
flow' reaction                                                                                       17


                                    Company Confidential - For Internal Use Only
                                Copyright © 2010, SAS Institute Inc. All rights reserved.
18


    Company Confidential - For Internal Use Only
Copyright © 2010, SAS Institute Inc. All rights reserved.
Manual Review of Text for “Other”

 Most were not adverse events that persisted
 Some seemed like “FYI” reports.
 Two included notification of a formal study
 Most patients still had the stent in place (assumed)
 Some cases of installation problems:
    Potential installer error
    Most did not involve an adverse event




                                                                                      19


                              Company Confidential - For Internal Use Only
                          Copyright © 2010, SAS Institute Inc. All rights reserved.
Conclusion

 Text mining shows promise for recognizing
  primary words and patterns
 Hard to form hypotheses from bulk text mining on
  spontaneous database
 Combination with disproportionality analysis
  creates signals that can be further analyzed with
  text mining
 Terms in the “Other” category overlap with other
  categories

                                                                                    20


                       Company Confidential - For Internal Use Only
                                                                               20
                   Copyright © 2010, SAS Institute Inc. All rights reserved.
Next Steps

Need further analysis that includes:
 Large target group for further triage
    “Other” was too small in this case
 Preferred term matching and encoding
    To clean up fuzziness and reduce clusters
 Content categorization
    Look for more structure and combine with ontologies
 Sentiment analysis
    Determine if overall sentiment was good or bad



                                                                                         21


                            Company Confidential - For Internal Use Only
                                                                                    21
                        Copyright © 2010, SAS Institute Inc. All rights reserved.
Final Thoughts
“What the future portends is more and more
information — Everests of it. There won’t be
anything we won’t know. But there will be no
one thinking about it.”
   From:
   New York Times - August 13, 2011
   The Elusive Big Idea
   By NEAL GABLER

   Neal Gabler is a senior fellow at the Annenberg Norman Lear Center at the University of
   Southern California and the author of “Walt Disney: The Triumph of the American Imagination.”




We need to help make time for thinking.
                                                                                                   22


                                       Company Confidential - For Internal Use Only
                                   Copyright © 2010, SAS Institute Inc. All rights reserved.
Thank You
Contacts:

 Eric Brinsfield  eric.brinsfield@sas.com

 David Olaleye  david.olaleye@sas.com




                       Company Confidential - For Internal Use Only
                   Copyright © 2010, SAS Institute Inc. All rights reserved.

More Related Content

PDF
Ophthalmology Innovation Showcase 1 - Aerie Pharmaceuticals
PPTX
Search Engine Optimization Specialists
PPT
Flying dutchman
PDF
سفر اشعياء
PPT
Sir chris odonnel
PPTX
Dave Page – Exploding Website Conversion
PPT
NAA shake your family tree talk 2012
PPTX
Amigos
Ophthalmology Innovation Showcase 1 - Aerie Pharmaceuticals
Search Engine Optimization Specialists
Flying dutchman
سفر اشعياء
Sir chris odonnel
Dave Page – Exploding Website Conversion
NAA shake your family tree talk 2012
Amigos

Viewers also liked (13)

PDF
Evaluation of as media
PPT
Unit 4
DOCX
Speech
PPTX
Izispot diapo
PPTX
Evaluation – Bryn Hughes
PDF
Electro-Thermal and Semiconductivity Behaviour of Natural Sintered Complex Ca...
PPT
חינוך טכנולוגי
PDF
Ozel egitim-video
PDF
Brochure SVT English
PPT
PDF
2014 451782
PDF
ARC 404/504 Presentation
PDF
Ozel pilot-okulu
Evaluation of as media
Unit 4
Speech
Izispot diapo
Evaluation – Bryn Hughes
Electro-Thermal and Semiconductivity Behaviour of Natural Sintered Complex Ca...
חינוך טכנולוגי
Ozel egitim-video
Brochure SVT English
2014 451782
ARC 404/504 Presentation
Ozel pilot-okulu
Ad

Similar to Text Mining the MAUDE Database (20)

PPTX
SAS healthcare workshop 18 nov 2011
PDF
Cytel White Paper | ACES
PDF
cytel-white-paper-aces-silva
PPTX
Is Big Data Always Good Data?
PDF
Medical device-consumer-workshop
PDF
Using real-time-data-to-drive-better-decisions-faster
PPTX
How to Use Text Analytics in Healthcare to Improve Outcomes: Why You Need Mor...
PPS
ASTER results at 2009 DIA
PPT
Planning And Development Of The Iss Ise Webinar Final
PDF
1st CUTEHeart Workshop Resnic Presentation
PPTX
Presentation: Medical Devices: how to stay included workshop - Adverse event ...
DOCX
Big Data Risks and Rewards (good length and at least 3-4 references .docx
PDF
SAS M2007 Presentation
PPTX
FDA Guidance on EFS: The Device Evaluation Strategy Challenges
PDF
Practical Guide - www.devicematters.com
KEY
Data Driven Practice with e-MDs
PDF
AHRQ Reporting Patient Safety challenge submission from IDinc and Shands Heal...
PDF
Patient Safety the dutch way
PDF
Atrial Fibrillation from an Engineering Perspective Leif Sörnmo
PPTX
MED dra Coding -MSSO
SAS healthcare workshop 18 nov 2011
Cytel White Paper | ACES
cytel-white-paper-aces-silva
Is Big Data Always Good Data?
Medical device-consumer-workshop
Using real-time-data-to-drive-better-decisions-faster
How to Use Text Analytics in Healthcare to Improve Outcomes: Why You Need Mor...
ASTER results at 2009 DIA
Planning And Development Of The Iss Ise Webinar Final
1st CUTEHeart Workshop Resnic Presentation
Presentation: Medical Devices: how to stay included workshop - Adverse event ...
Big Data Risks and Rewards (good length and at least 3-4 references .docx
SAS M2007 Presentation
FDA Guidance on EFS: The Device Evaluation Strategy Challenges
Practical Guide - www.devicematters.com
Data Driven Practice with e-MDs
AHRQ Reporting Patient Safety challenge submission from IDinc and Shands Heal...
Patient Safety the dutch way
Atrial Fibrillation from an Engineering Perspective Leif Sörnmo
MED dra Coding -MSSO
Ad

Text Mining the MAUDE Database

  • 1. Signal Detection of Adverse Medical Device Events in the FDA MAUDE Database Eric Brinsfield, MS Presenter & Research Collaborator David Olaleye, MSCE, PhD Author & Primary Research Statistician SAS Institute Inc. Cary, NC Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 2. Disclosure Statement  Both presenters are employees of SAS Institute  We have no conflicts of interest Disclaimer The views and opinions expressed in the following PowerPoint slides are those of the individual presenters and should not be attributed to ISPE or to SAS Institute. 2 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 3. Study Objectives Determine if text mining can be used to:  Detect signals of adverse events in spontaneous reporting data  Better understand or triage signals generated by traditional disproportionality methods Phase 1:  Evaluate unsupervised text mining  Using FDA MAUDE database  Focused on stents 3 Company Confidential - For Internal Use Only 3 Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 4. Definitions  Safety Signal  “A report or reports of an event with an unknown causal relationship to treatment that is recognized as worthy of further exploration and continued surveillance.” » Council for International Organizations of Medical Sciences (CIOMS)  “Recognition” is often the results of  Analytical or automatic signal detection methods that look for unexpected patterns in data sources such as: » Spontaneously reported data » Observational healthcare data » Insurance claims data 4 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 5. Methods  Data Source = MAUDE  FDA Spontaneous Reporting System Database for Med. Devices MAUDE - Manufacturer and User Facility Device Experience  Contains the narrative entered by the reporter  Target Devices  endovascular graft system and coronary stent devices  devices classified as a stent in the “product_category_code”: » MAF, MIH, NIN, NIO, NIP, NIM, and NIQ » http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPCD/classif ication.cfm?ID=896 5 Company Confidential - For Internal Use Only 5 Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 6. MAUDE (2001-2008) Spontaneous “safety” reports on medical devices Strengths:  Only surveillance system which covers devices marketed in the entire US  Largest number of case reports on adverse outcomes and malfunctions for medical devices  Provides opportunity to detect signals of new, rare and unusual adverse clinical outcomes » Usually warrants further investigation  Includes narrative description of events » Better than AERS which does not include narrative 6 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 7. Characteristics of Spontaneous Report  Suitable for hypotheses generation; not for confirmation or rates computation  Exhibit under-reporting and other reporting biases; lack of control group, etc.  Data quality, ascertainment, accuracy and completeness of information are usually poor  Includes events and incidents not causally related to medical device exposure  Does not distinguish between label versus off-label uses of approved products  Contains minimal or no patient history and other potential causal factors  Do not provide estimates of exposure (worse in drugs) 7 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 8. Study Design: Case-Series Source Population All MAUDE reports received between 2006 – 2010 (N=35954) Study Device Cohort Study Events MAUDE reports for stents • Death (D) with product codes: • Injury (I) MAF, MIH, NIN, NIO, • Malfunctions (M) NIP, NIM, and NIQ • Other (O) Device-Adverse Outcomes Pairs (N=28) 8 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 9. Analysis Steps 1. Attempt analysis using text mining alone  Ignore device  Evaluate if general text mining provides any insights 2. Perform standard disproportionality analysis on structured data  PRR, EBGM, Adj. Residual 3. Identify device-AE pairs that have:  High scores  Especially in the “Other” classification 4. Investigate the device with text mining  Include all outcome classifications 9 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 10. Text Mining Process  Parse terms to create documents-terms frequency matrix  Use singular value decomposition (SVD) to measure association and perform hierarchical clustering  Use entropy method to cluster SVDs for documents classification 10 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 11. Sample Narrative - Injury Example of Manufacturer Report - Injury  the product labeling for a p154 states that this product is indicated for use in pts with obstruction of major biliary ducts. the product labeling also states that the stent may be increased post-placement by expanding with a larger diameter balloon. the following was obtained through conversation with the user facility on 1/15/98. after deciding that a ptca procedure in a renal artery did not yield adequate results, the md attempted to place a medium biliary stent in the artery. the physician reported to co. that he had difficulty visualizing the stent and that it was difficult to place. he deployed the stent, but was not satisfied with the outcome. in response, he decided to place a second stent inside of the first. however, the stents interlocked and the physician decided to remove both stents, he was able to withdraw the stent up to sheath tip in the femoral artery, but needed a vascular surgeon to completely remove them. info regarding the type of removal procedure has not been provided to co. the physician further stated that he believes that the first stent had not fully opened. it was mounted on a meditech glidex balloon. 11 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 12. Concept Linking and Exploration 12 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 13. Text mining clusters over all reports 13 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 14. Text Mining Over All Reports  Results are interesting  But inconclusive  Lose track of the device  But may detect new trends for all stent devices in study Cannot really do comparisons due to lack of denominator. (Same problems as always with spontaneous reports.) Next, run disproportionality to narrow the focus… 14 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 15. Disproportionality Results for Carotid Stent (NIM) Adjusted MGPS Adverse Event Freq Residual (EBGM) Death 276 0.8 0.86728 Injury 2043 1.1 1.130264 Malfuntion 271 0.4 0.424803 Other 24 1.6 3.648191 * Adjusted Residual: Flagged at values over 1.5 EBGM: Flagged at values over 2.0 15 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 16. Target for Text Mining Evaluation  NIM showed high proportion of “Other”  Based on relative percentage of reports  Based on signal scoring algorithms  All methods suggested a flag  Although only 24 cases, the method could show promise  Run text mining against all NIM reports  Include all outcomes to fully understand reports  Look for possible explanations or hypotheses 16 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 17. N Text Mining Clusters for NIM +percutaneous +unk dissection performance +unstable repaired 376 +malfunction 'device remains implanted' reactions collapsing +'premature deployment' cracks +'product quality 41 issue' replaced performance collapsed malfunction fractures +fracture +'inaccurate delivery' fractured 846 malfunctions drift +'premature deployment' +normal dissection +unk 'no information' +na collapsing unk fractured 69 'device issue' broke 'no known device problem' +break broken +'shaft 227 break' reaction reactions abnormal +fracture +continuous +bent cracks unk +break fractured 65 filter +na 'difficult to advance' breaks reaction +bent +malfunction 150 replaced 'device remains implanted' collapsed 'no flow' performance +crack 44 +break +collapse filter fractured repair +crack breaks +collapse +'product quality issue' 'no 31 flow' reaction 17 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 18. 18 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 19. Manual Review of Text for “Other”  Most were not adverse events that persisted  Some seemed like “FYI” reports.  Two included notification of a formal study  Most patients still had the stent in place (assumed)  Some cases of installation problems:  Potential installer error  Most did not involve an adverse event 19 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 20. Conclusion  Text mining shows promise for recognizing primary words and patterns  Hard to form hypotheses from bulk text mining on spontaneous database  Combination with disproportionality analysis creates signals that can be further analyzed with text mining  Terms in the “Other” category overlap with other categories 20 Company Confidential - For Internal Use Only 20 Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 21. Next Steps Need further analysis that includes:  Large target group for further triage  “Other” was too small in this case  Preferred term matching and encoding  To clean up fuzziness and reduce clusters  Content categorization  Look for more structure and combine with ontologies  Sentiment analysis  Determine if overall sentiment was good or bad 21 Company Confidential - For Internal Use Only 21 Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 22. Final Thoughts “What the future portends is more and more information — Everests of it. There won’t be anything we won’t know. But there will be no one thinking about it.” From: New York Times - August 13, 2011 The Elusive Big Idea By NEAL GABLER Neal Gabler is a senior fellow at the Annenberg Norman Lear Center at the University of Southern California and the author of “Walt Disney: The Triumph of the American Imagination.” We need to help make time for thinking. 22 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 23. Thank You Contacts: Eric Brinsfield  eric.brinsfield@sas.com David Olaleye  david.olaleye@sas.com Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.